Role of Killer Immunoglobulin-Like Receptor and Ligand Matching in Donor Selection

Abstract EN

Despite all efforts to improve HLA typing and immunosuppression, it is still impossible to prevent severe graft versus host disease (GVHD) which can be fatal.

GVHD is not always associated with graft versus malignancy and can prevent stem cell transplantation from reaching its goals.

Overall T-cell alloreactivity is not the sole mechanism modulating the immune defense.

Innate immune system has its own antigens, ligands, and mediators.

The bridge between HLA and natural killer (NK) cell-mediated reactions is becoming better understood in the context of stem cell transplantation.

Killer immunoglobulin-like receptors (KIRs) constitute a wide range of alleles/antigens segregated independently from the HLA alleles and classified into two major haplotypes which imprints the person's ability to suppress or to amplify T-cell alloreactivity.

This paper will summarize the impact of both activating and inhibitory KIRs and their ligands on stem cell transplantation outcome.

The ultimate goal is to develop algorithms based on KIR profiles to select donors with maximum antileukemic and minimum antihost effects.